Treatment for Anaphylaxis Due to Wasp Sting in Individuals with Known Allergy
Immediate intramuscular epinephrine is the first-line treatment for anaphylaxis due to wasp sting in individuals with known allergies, and should be administered without delay. 1, 2, 3
Immediate Management
Administer epinephrine immediately:
- Dose: 0.01 mg/kg (up to 0.3 mg) in children; 0.3-0.5 mg in adults depending on severity
- Route: Intramuscular injection in the anterolateral thigh (achieves faster and higher plasma concentration than subcutaneous or arm injection)
- Timing: Critical - delayed use can be ineffective or fatal 1
- Repeat dosing may be required for persistent or recurrent symptoms
Remove stinger (if present):
Supportive care:
- Position patient appropriately (supine with legs elevated if hypotensive)
- Establish IV access
- Administer oxygen if needed
- Monitor vital signs
Additional medications (only after epinephrine):
Important Clinical Considerations
- Antihistamines and corticosteroids are NOT substitutes for epinephrine in anaphylaxis 1
- No contraindication to epinephrine in life-threatening anaphylaxis, even in patients with cardiovascular disease 1
- Observation period: Monitor for 4-12 hours after initial reaction to watch for biphasic reactions 2, 4
- Risk factors for severe reactions: Older age, cardiovascular disease, asthma, high baseline serum tryptase, short latency time after sting, and absence of skin symptoms 5
Long-term Management
Prescription for auto-injectable epinephrine:
Referral to allergist-immunologist for patients who have experienced systemic reactions to:
Avoidance measures:
Medical identification:
- Consider medical ID bracelet or necklace 1
Common Pitfalls to Avoid
- Delaying epinephrine administration - this is associated with fatal outcomes 1, 2
- Relying on antihistamines or corticosteroids alone - these are adjunctive treatments only 1
- Poor patient education - many patients with venom allergies have incorrect ideas about after-sting behavior and improper technique with auto-injectors 6
- Inadequate follow-up - failure to refer to an allergist for long-term management and consideration of immunotherapy 1, 2
- Insufficient observation time - patients should be monitored for biphasic reactions 4
The evidence clearly demonstrates that prompt administration of epinephrine is the cornerstone of anaphylaxis management, with delayed use potentially leading to fatal outcomes. Long-term management should focus on prevention through education, avoidance strategies, and consideration of venom immunotherapy.